Announcements Trials
Browse Landscape

Status

Available 1

Sponsor Class

OTHER 1

Study Type

Interventional 24Expanded_access 1

Sponsor

Cancer Type

CNS 1

Conditions

Typical Teratoid Rhabdoid Tumor 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Medulloblastoma 1

Interventions

3-Iodobenzylguanidine 6Magnetic Resonance Spectroscopy 5Amifampridine 5gallium 68 PSMA-11 4fludarabine phosphate 4Cyclophosphamide 4fludarabine 3pembrolizumab 2fluorodopa F 18 2carbon-11 acetate 2Whole-Body Irradiation 2Oxaliplatin 2Insulin Infusion Systems 2Ga(III)-DOTATOC 2Fluorouracil 2Bortezomib 2Bone Marrow Transplantation 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2venetoclax 1veliparib 1ulocuplumab 1trametinib 1selinexor 1ponatinib 1pegfilgrastim 1omburtamab I-131 1nirogacestat 1neratinib 1navitoclax 1motexafin gadolinium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Expanded_access × Eflornithine × Clear all
NCT03581240 2026-02-20

An Intermediate Expanded Use Trial of DFMO

Milton S. Hershey Medical Center

Available
CNS

Typical Teratoid Rhabdoid Tumor, Medulloblastoma, Neuroblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡